...mmonwealth University Massey Cancer Center have id...ible new therapeutic target to improve the efficac...In the Nov. 1 issue of the journal Cancer Research...er cells and established a role of sphingosine kin...id mediator sphingosine-1-phosphate in the death o...
...the world is still plagued by diseases we cannot t...ast complexity of the human immune system. Danish ... help expose a complicated but crucial part of the...an lead to entirely new vaccines and treatments. ... of Health Sciences at the University of Copenhage...
...can contribute as much as vehicles to carbon emiss...hly variable. New research published in the online... quantifies these emissions and suggests fires wil...forts. , Christine Wiedinmyer of the National Cen... University of Colorado, both in Boulder, US, used...
Other Biology News:Potential new therapeutic molecular target to fight cancer 2US faces burning emissions issue 2(Date:11/25/2009)...ire-FirstCall/--ArdeaBiosciences,Inc.(Nasdaq: RDEA...tandchiefexecutiveofficer,willpresentatthePiperJaf...ondetailsareasfollows:,PiperJaffray21stAnnualHeal...2:00p.m.EasternTime,Location:TheNewYorkPalaceHotel...r.net/ireye/,target=,_blank,title=,http://www.cor...
(Date:11/24/2009)...ew York investment bank KTA Capital,s client Neure....7 mil convertible note private placement with a U...was arranged by KTA Capital as Neuren,s exclusive ... New York (PRWEB) November 23, 2009 -- The in...C ("KTA Capital") has announced that its...
(Date:11/24/2009)...ire-FirstCall/--Sigma-AldrichCorporation(Nasdaq: S...sday,December1stat1:45PMGMTinLondon,7:45AMUS/CST.I...theInternetavailableat http://inve s tor.sig m...ntoaccessthisfile. ,, AboutSigma-Aldrich: Si...ompany.Itschemicalandbiochemicalproductsandkitsare...
(Date:11/24/2009)...PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX...commercializingnovelpainmanagementtherapies,announ...iveOfficer,isscheduledtopresentatthe21stAnnualPipe...009atTheNewYorkPalaceHotelinNewYork,NewYork. ,,...er,willbeavailabletorespondtoquestionsduringthepre...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3